US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Guardant Health, Inc. - Common Stock
(NQ:
GH
)
178.80
-6.51 (-3.51%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Guardant Health, Inc. - Common Stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
23
24
Next >
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
↗
September 16, 2024
Via
Benzinga
Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types
September 13, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy
September 10, 2024
From
Guardant Health, Inc.
Via
Business Wire
Key Takeaways From Guardant Health Analyst Ratings
↗
August 08, 2024
Via
Benzinga
Assessing Guardant Health: Insights From 7 Financial Analysts
↗
July 17, 2024
Via
Benzinga
Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 27, 2024
From
Guardant Health, Inc.
Via
Business Wire
Why Guardant Health Stock Just Crashed 10%
↗
August 26, 2024
Guardant Health needs cash. Until it can get it from selling enough services, it must sell its own shares instead.
Via
The Motley Fool
PDD Holdings, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
August 26, 2024
Via
Benzinga
Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)
August 23, 2024
Via
AB Newswire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
August 23, 2024
The widely followed growth investor is making moves this summer.
Via
The Motley Fool
Guardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield™ Blood Test for Colorectal Cancer Screening
August 22, 2024
From
Guardant Health, Inc.
Via
Business Wire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
August 12, 2024
The widely followed growth investor was a buyer at the end of a very volatile trading week.
Via
The Motley Fool
Cathie Wood's Ark Invest Continues Loads Up On $6.05M Worth Of Robinhood Shares Amid Bitcoin Rebound, Dumps Zoom Stock
↗
August 08, 2024
On Thursday, Cathie Wood-led Ark Invest made some significant trades, notably buying Robinhood Markets Inc (NASDAQ:HOOD) and selling Zoom Video Communications Inc (NASDAQ:ZM).
Via
Benzinga
Guardant Health to Participate in Upcoming Investor Conferences
August 08, 2024
From
Guardant Health, Inc.
Via
Business Wire
GH Stock Earnings: Guardant Health Beats EPS, Beats Revenue for Q2 2024
↗
August 07, 2024
GH stock results show that Guardant Health beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Guardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
August 07, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Colorectal Cancer
August 07, 2024
From
Guardant Health, Inc.
Via
Business Wire
Why Exact Sciences, Up 20%, Is 'Coiled To Snap Back' After Quarterly Beat
↗
August 01, 2024
The company expects stronger second-half sales vs. the first half of 2024.
Via
Investor's Business Daily
Guardant Health’s FDA-approved Shield™ Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer
August 01, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Outcomes Model Confirms the Public Health Importance of Enhanced Colorectal Cancer Screening Outcomes with High Adherence Strategies
August 01, 2024
From
Guardant Health, Inc.
Via
Business Wire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
July 31, 2024
The strugglingh stock investor did a little bit of shopping on Tuesday, adding to some of her existing positions.
Via
The Motley Fool
FDA Greenlights Guardant Health's Shield Blood Test, Analyst Cautious on Adoption
↗
July 29, 2024
FDA approves Guardant Health's Shield blood test for colorectal cancer screening in adults 45+, marking the first FDA-approved blood test as a primary CRC screening option. Shield meets Medicare...
Via
Benzinga
Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening
July 29, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Report Second Quarter 2024 Financial Results on August 7, 2024
July 24, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360® Test, Further Extending Its Best-in-Class Performance
July 23, 2024
From
Guardant Health, Inc.
Via
Business Wire
Goldman Sachs Says Buy These 3 Stocks for Double-Digit Returns
↗
July 22, 2024
The investment banking firm says these companies are among the best stocks to buy and have some strong tailwinds behind them.
Via
InvestorPlace
3 Precision Medicine Stocks Tailoring Treatments
↗
July 21, 2024
With technological developments pushing the boundaries of healthcare, these are the precision medicine stocks to consider.
Via
InvestorPlace
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
↗
July 18, 2024
Via
Benzinga
Dr. Manuel Hidalgo Medina Joins Guardant Health Board of Directors
July 18, 2024
From
Guardant Health, Inc.
Via
Business Wire
3 Biotech Moonshots With Imminent Catalyst Potential
↗
July 03, 2024
Biotech has been one of the most explosive sectors. Better, further upside is likely, thanks to some of the top biotech stocks with catalysts.
Via
InvestorPlace
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
23
24
Next >
